Search Results 81-90 of 16983 for EBV

  1. Burkitt lymphoma - Diagnosis and treatment - Mayo Clinic

    Blood tests also can check for infections that may increase the risk of Burkitt lymphoma, such as Epstein-Barr virus and HIV. Imaging tests. Imaging tests ...

  2. Abatacept (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

    Virus infection (eg, Epstein-Barr virus, cytomegalovirus), history of—Use with caution. May make these conditions worse. Infections (eg, hepatitis B ...

  3. Lung volume reduction surgery - Mayo Clinic

    Endobronchial valve (EBV) therapy. American Heart Association. https://www.lung.org/lung-health-diseases/lung-procedures-and-tests/ebv-therapy. Accessed Nov ...

  4. Transplant Medicine Resource Center - Medical Professionals - Mayo Clinic

    Cellular Immunotherapy for Viral Induced Cancer - EBV Positive Lymphomas. Rochester, Minn. Concomitant Renal and Urinary Bladder Allograft Transplantation.

  5. A Study of Donor-Alloantigen-Reactive Regulatory T Cell Therapy with an Immunosuppression Regimen in Adult Liver Transplantation - Mayo Clinic

    Epstein-Barr Virus (EBV) or cytomegalovirus (CMV) sero-negativity (EBV or CMV naïve candidates). Chronic use of systemic glucocorticoids or other ...

  6. Salivary gland tumors - Symptoms and causes - Mayo Clinic

    People who have had viral infections such as Epstein-Barr virus, human immunodeficiency virus and human papillomavirus may have a higher risk of salivary gland ...

  7. A Study of the Benefits and Risks of Nulojix® (Belatacept)-Based Maintenance Immune Rejection Suppression for Kidney Transplant Recipients - Mayo Clinic

    Recipients with Epstein-Barr virus (EBV) serostatus negative or unknown; History of acute rejection (AR) within 3 months prior to enrollment; History of ...

  8. Virotherapy Clinical Trials - Mayo Clinic Research

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL) ...

  9. A Study of Nulojix® (Belatacept) as Maintenance Immunosuppression in Kidney Transplant Recipients - Mayo Clinic

    Participation eligibility · Recipients with Epstein-Barr virus (EBV) serostatus negative or unknown · History of acute rejection within 3 months prior to ...

  10. Impact of Proteasome Inhibition on Anti-Donor HLA Antibody Production After Kidney Transplantation - Mayo Clinic

    EBV sero-negative recipients. History of CMV + or EBV + viremia since transplantation. History of HCV positivity (by PCR). History of Post-transplant ...